Pulmonary amyloidosis - The Mayo Clinic experience from 1980 to 1993

被引:239
作者
Utz, JP [1 ]
Swensen, SJ [1 ]
Gertz, MA [1 ]
机构
[1] MAYO MED CTR, ROCHESTER, MN USA
关键词
amyloidosis; biopsy; bronchoscopy; amyloid; respiratory tract diseases;
D O I
10.7326/0003-4819-124-4-199602150-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To define the prognosis for and radiographic presentation of patients with pulmonary amyloidosis. Design: Retrospective review of the Mayo Clinic experience with biopsy-proven pulmonary amyloidosis from 1980 to 1993. Setting: Tertiary care center. Patients: Patients with pulmonary biopsy specimens showing amyloid deposition. Measurements: Medical records were reviewed, and pertinent information was recorded, including demographic data, type of pulmonary biopsy, results of biopsies of nonpulmonary sites and of immunoelectrophoresis, and other clinical, radiographic, and laboratory information necessary for distinguishing localized pulmonary amyloidosis, primary systemic amyloidosis, secondary amyloidosis, and familial amyloidosis. Results: 35 of 55 patients with pulmonary amyloidosis had primary systemic amyloidosis that presented radiographically as an interstitial or reticulonodular pattern with or without pleural effusion. The median survival after diagnosis was 16 months. Nodular pulmonary ''amyloidomas'' (nodular amyloid lesions) were not associated with systemic disease and were associated with a benign prognosis. Three of 4 patients with localized tracheobronchial amyloidosis required Nd:YAC (neodymium:yttrium-aluminum-garnet) laser therapy for obstructive symptoms. ''Senile'' amyloid deposition was an incidental finding in some patients at autopsy. Conclusions: Localized amyloidomas are characterized by a benign course and are not associated with systemic amyloidosis. Despite its localized nature, tracheobronchial amyloid deposition may be asymptomatic or may result in significant morbidity due to obstructive phenomena. Pulmonary amyloidosis associated with primary systemic amyloidosis generally presents as a diffuse interstitial pattern with or without pleural effusion. Complete survival data indicate that long-term outcome is poor after diagnosis. We describe the largest series of patients diagnosed by bronchoscopic lung biopsy. Despite reports to the contrary, we have found bronchoscopic lung biopsy to be a safe and effective diagnostic technique.
引用
收藏
页码:407 / +
页数:1
相关论文
共 48 条
  • [1] TRACHEOBRONCHOPATHIA OSTEOPLASTICA - END STAGE OF PRIMARY LUNG AMYLOIDOSIS
    ALROY, GG
    LICHTIG, C
    KAFTORI, JK
    [J]. CHEST, 1972, 61 (05) : 465 - &
  • [2] BIERNY JP, 1978, AM J ROENTGENOL, V131, P1082
  • [3] TRACHEO-BRONCHIAL AMYLOIDOSIS - TREATMENT BY CARBON-DIOXIDE LASER PHOTORESECTION
    BREUER, R
    SIMPSON, GT
    RUBINOW, A
    SKINNER, M
    COHEN, AS
    [J]. THORAX, 1985, 40 (11) : 870 - 871
  • [4] BUXBAUM JN, 1988, CECIL TXB MED, P1198
  • [5] CANDEIRA SR, 1991, CHEST, V100, P292, DOI 10.1378/chest.100.1.292-a
  • [6] PATTERNS OF PULMONARY INVOLVEMENT IN SYSTEMIC AMYLOIDOSIS
    CELLI, BR
    RUBINOW, A
    COHEN, AS
    BRODY, JS
    [J]. CHEST, 1978, 74 (05) : 543 - 547
  • [7] AMYLOIDOSIS OF THE LOWER RESPIRATORY-TRACT - CLINICAL AND PATHOLOGICAL FEATURES IN A SERIES OF 21 PATIENTS
    CORDIER, JF
    LOIRE, R
    BRUNE, J
    [J]. CHEST, 1986, 90 (06) : 827 - 831
  • [8] DAHLGREN SE, 1970, ACTA PATH MICRO IM A, VA 78, P1
  • [9] DAHLIN DC, 1950, MED CLIN N AM, P1107
  • [10] DAIL DH, 1988, PULMONARY PATHOLOGY, P535